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1. Introduction
Laparoscopic Sleeve Gastrectomy (LSG) is an increasingly popular procedure for weight loss.
Compared to other bariatric procedures, sleeve gastrectomy remains a relatively young stand-
alone weight loss operation. However, despite being relatively new it has gained grounds not
only in the west where bariatric surgery has been around for long but also in Asia where it is
increasingly becoming the procedure of choice for weight loss [1, 2]. Its attractiveness is
attributed not only to its significant weight loss outcome, but also the technical austerity of the
operation as well as the significant improvement or remission of medical co morbidities.
1.1. History
Sleeve gastrectomy may be seen as an extension of the Magenstrasse and Mill procedure.
The first open sleeve gastrectomy was performed in March 1998 by Doug Hess [3]. A year
later, the first laparoscopic duodenal switch with a sleeve gastrectomy was reported on a
porcine model [4]. LSG was first performed in 2000, by Gagner et al as part of a duode‐
nal switch procedure and he subsequently also reported sleeve gastrectomy after BPD/DS
as  a  salvage  procedure  for  poor  weight  loss  [5,  6].  Regan  et  al.  then  reported  sleeve
gastrectomy as a first step for sufficient weight loss prior to performing a more definite
procedure  such as  Roux-en-Y bypass  or  duodenal  switch  in  high-risk  obese  patients  to
decrease mortality and morbidity [7].
1.2. Indications
The NIH Consensus conference [8] in 1991 stipulated that patients with BMI equal to or
exceeding 40kg/m2 or patients with high risk co-morbid conditions and BMI exceeding or
equal to 35 kg/m2  were candidates for bariatric surgery. For Asian patients, the BMI cut-
off  is  2.5kg/m2  lower  [9].  More  recently,  the  International  Sleeve  Gastrectomy  Expert
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Consensus  Statement  stipulated that  laparoscopic  sleeve  gastrectomy (LSG)  was  a  valid
stand-alone procedure for patients with metabolic syndrome as well as patients with a BMI
of 30 – 35 kg/m2 in presence of associated comorbidities [10]. Obese patients with Child’s
A or B liver cirrhosis, inflammatory bowel disease or potential transplant recipients were
also potential candidates for LSG [10]. LSG was also deemed suitable for morbidly obese
patients in their adolescence as well as elderly morbidly obese patients. Medical tourism is
on the rise and people traveling from far-fetched regions with minimal support may seek
bariatric surgery and once stationed back in their remote locations may not have access to
care needed for maintenance. A very low of long term complications is seen as an advantage
to recommend this procedure.
1.3. Contraindications
LSG has been reported to increase the incidence of gastroesophageal reflux disease (GERD)
[11]. A history of GERD is a relative contraindication for undergoing laparoscopic sleeve
gastrectomy as their symptoms might worsen after surgery and these patients may be better
served with other procedures e.g. gastric bypass [12].
Caution should be exercised in patients with concurrent Barrett’s Esophagus. Performing a
sleeve gastrectomy will decrease the amount of gastric tissue available for creation of a gastric
tube after esophagectomy if there is malignant progression of the Barrett’s Esophagus. LSG is
preferred and favored over Roux-en-Y bypass in patients / regions at high risk of developing
gastric cancer as performing the latter procedure will make endoscopic surveillance of the
remnant stomach for cancer almost impossible.
2. The procedure
2.1. Preoperative considerations
The preoperative management does not differ from other bariatric procedures. Patients with
a history of smoking should be encouraged to stop smoking. Dietary counseling should be
mandatory and should address preoperative weight loss, immediate and long term diet
recommendations after sleeve gastrectomy. Initiation of a low calorie diet prior to surgery
should be considered as this helps shrink the large fatty liver and thus optimizes intra-
abdominal operating space. Investigations to evaluate peri-operative risk, exclude other causes
of obesity and those on long term follow up nutritional monitoring are a norm. A visit to a
physiotherapist, psychologist, pulmonologist, anesthetist and other physicians should be
considered on need basis. The role of a multidisciplinary team to manage these patients cannot
be further emphasized [13].
2.2. Technique
a. Positioning
It should be ensured that the operating table has the capacity to support the weight of the
patient. The patient may be positioned supine or in French position with legs apart (Figure
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1). The feet are secured to the foot board so that reverse trendeleburg position is possible. The
arms should be well padded to prevent neurological injury should the arms be stretched out
and secured to an arm board. Once the patient is strapped down, the table should be tilted to
extremes to ensure that the patient is well secured and would not slip off the table (Figure 2).
Figure 1. French position
Figure 2. Patient secured on operating table
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b. Decompression of the stomach
This can be achieved by insertion of orogastric tube, a hollow calibration tube by gastroscopy.
We insert our disposable 38F calibration tube after positioning the patient and prior to draping.
In doing so, we are able to empty the gastric contents prior to surgery and during surgery, to
maneuver the calibration tube to size the sleeve. The insertion of a calibration tube is not
without problems. If one faces resistance during insertion of it is better to use a gastroscope or
colonoscope as calibration tube. There are reports of esophageal perforation resulting from
improper handling of calibration tubes [14].
c. Port placement
5 ports are typically inserted for LSG in our patients. A 10-12 optical trocar is inserted 20 cm
below the left costal margin along the midclavicular line to gain access to the abdominal cavity.
Other techniques like the use of Veress needle and open Hassan technique may be used. A
5mm epigastric port is inserted for introduction of a liver retractor. For patients where the
distance between the xyphoid and umbilicus is up to 35cm we insert an infra-umbilical 15mm
port as the working port for the surgeon. If the distance is more or the patient has central
obesity this port is changed to a 10-12mm port that is placed approximately 20cm from xyphoid
to the left of the mid line. Two 5mm ports are inserted in the left and right hypochondria regions
of the patient for assistant and surgeon (Figure 3).
Figure 3. Port placement
d. Measurement of the Antral pouch:
Once pneumoperitoneum is established, a diagnostic laparoscopy is performed and hepatic
steatosis assessed. The greater gastrocolic omentum is divided 5 cm from the pylorus with the
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aid of an energy device (Figure 4). There is consensus among bariatric surgeons that the antral
pouch should be measured 2-6cm from the pylorus along greater curve [10] as risk benefit ratio
is best within these limits. However, some surgeons also believe that cutting too close to
pylorus increases risk of leak and most would prefer to stay 4-6cm away. Michalsky D et al
compared patients who underwent radical resection of antrum (resection 2.5cm from pylorus)
versus those with preserved antrum (resection 6cm from pylorus), they found no difference
in % excess weight loss, complications, gastric emptying and food retention between both
groups [15].
Figure 4. Measuring antral pouch
e. Devascularization:
In the lateral technique, the devascularization process is continued up the greater curve of the
stomach to the short gastric vessels with the help of the assistant who maintains traction and
exposure during this process (Figure 5a&b). Eventually, one reaches the left crus which is an
important landmark of dissection (Figure 6). The left crus muscle is then routinely dissected
and hiatus explored by some for a hernia, while others may differ. We selectively explore the
hiatus of the symptomatic and endoscopically proven hiatus hernia as all our patients are
evaluated for symptoms of reflux by questionnaire pre-operative and also have a gastroscopy
performed. In patients with hiatus hernia, the hernia should be reduced and the defect
repaired.
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Figure 5. a) Gaining entry into lesser sac, (b) Division of gastro colic ligament
Figure 6. Exposure of left crus of diaphragm
In the medial approach, once the lesser sac is entered the process of stapling starts and
devascularization is done only upon completion of sleeve. Dapri et al randomized 20 patients
to each arm and looked at the technical outcomes of both medial and lateral approaches; they
reported no difference in operative time, preoperative bleeding and hospital stay [16]
f. Gastric tube calibration
The 38 Fr Bougie inserted preoperatively is then advanced into the stomach along the lesser
curve. This serves as the border of transection with the linear staple with the remnant lesser
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curve forming the neo gastric pouch. One of the controversies lies in the optimal size of bougie
to be used to size the sleeve. Baltazar uses a 32-French bougie with transection starting at 2-3
cm from the pylorus [17] as opposed to Gagner using a bougie of 60-French bougie and starting
the transection at 10 cm away from the pylorus [6]. The bougie size does not affect mean excess
weight loss in the short-term but weight loss is significantly different in calibrated sleeves
compared to non calibrated sleeve [18]. The meta-analysis of Parikh et al did not show
significant difference in %EWL outcomes between bougie <40 Fr and bougie ≥40 Fr up to 36
months (mean: 70.1% EWL; P=0.273) [19]. All panelists in the Expert consensus statement
agreed that it was important to use a bougie to size the sleeve and the optimal size of the bougie
should be between 32 to 36F [10]. The use of a bougie < 32F may increase postoperative
strictures while using bougie of > 36F may bring about limited weight loss effects due to
possible dilatation of the sleeve. The size to tube finally achieved will also depend on other
factors like over sewing the staple line and whether ones’ stapling is snug or lax in relation to
the bougie.
g. Creating the gastric tube:
Linear transection of the stomach can be performed using 3.5mm, 3.8 mm or 4.1 mm staples
height depending on the thickness of the stomach wall. Any serosal tears during stapling
or excessive unexpected bleeding should be carefully evaluated as it  may be signaling a
poorly stapled area.  As the incisura is a common area of narrowing and in indicted for
being the cause of the high pressure system resulting in apical leaks in many patients, every
effort should be made to stay away and prevent narrowing during stapling. We mark our
stapling trajectory with a  marker  before  commencing stapling as  over  enthusiasm often
leads to disasters (Figure 7)
The use of staple-line reinforcement either through suturing or buttressing with biological or
synthetic material is a hotly debated topic. Perioperative and postoperative bleeding is a
concern for the staple line in sleeve gastrectomy and has been quoted to be between 0 to 14%
[20]. Methods to contravene this include the over sewing the staple line with non-absorbable
suture material, use of fibrin glue as well as the use of buttressing material along the suture
line. Several authors have advocated the use of buttress material to reduce staple line bleeding
and leak rates [21], while other reinforcement techniques do not reliably reduce staple line
leaks in sleeve gastrectomy [22, 23]. D’Ugo et al. found that in 1162 undergoing LSG, the overall
leak rate was 2.8%; Leak rate was lower in patients who had their staple line reinforced with
bovine pericardium strips (0.3%) compared to those with synthetic polyester (7.8%) or no
reinforcement (4.8%). Postoperative bleeding in patients who had staple line reinforcement
was lower (3% vs. 13.7%) [24]
In summary it is suffice to state that current evidence supports the use of buttress material to
decrease staple line bleeding [19]. However, buttress material may potentially lower leak rates
as it increases burst pressure but the evidence is of poor scientific strength to make a recom‐
mendation for their routine use to prevent leaks [23].
A New Emerging procedure — Sleeve Gastrectomy
http://dx.doi.org/10.5772/58844
107
h. Closure
The specimen is then delivered via the umbilical port (Figure 8). The staple line is then checked
for any leaks; we do not routinely oversew the staple line. The 15mm port site is then closed
with absorbable suture and the overlying skin stitched with a monofilament absorbable suture
after local anesthesia is administered.
Figure 8. Resected stomach
Figure 7. Marking prior to stapling
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3. Learning curve
Laparoscopic sleeve gastrectomy looks easy to perform, but yet is a technically demanding
procedure; it has to learned through proctorship and mentorship. LSG can be safely and
efficiently performed in a newly established bariatric center following a mentorship program.
Proficiency seems to require 68 cases. The operative time and hospital stay may significantly
decrease with experience early in the learning curve, as opposed to mortality and morbidity
rates, conversion rate, and %EWL which will likely remain unchanged [25].
3.1. Post-operative care
For our team, a standardized post operative pathway not only ensures quality care for patients
but also help juniors on call staff managing patients strategize management and know who to
call when the need arises. We stratify patients based on their ASA grade and the anesthesia
team will dictate their admission to intensive care, high dependency or general ward post-
operatively. We have standard pain control protocol to prevent narcotic overdose and yet
provide effective pain relief.
Clear fluids and ambulation are started on the day of surgery. Patients are reviewed by the
dietician and post-operative diet reinforced prior to being discharged home. A phone consult
is done 24-48hrs after discharge to reinforce hydration and to ensure patients are recovering
well. The clinician nurse, surgical team and dietician review patients 1-2 weeks postoperatively
as they slowly progress from clear feeds to soft diet within 4-6 weeks. We believe that the main
pillars leading to the success of the sleeve is long term nutritional care. Nutrition relies on a
professional medical team providing constant, ongoing patient support throughout all the
bariatric process stages working side by side. Patients are regularly reviewed by the dieticians
to re-enforce diet recommendations. Long-term, they are prescribed vitamin supplements as
advocated by the American Society of Bariatric and Metabolic Surgery guidelines for post
bariatric surgery patients [26]. Patients are educated on the need for regular follow up, alike
other batriatric procedures. Keren D et al reported improved weight loss and better comor‐
bidity outcomes for those with regular follow up. A total 119 patients were followed up for 30
months with the mean percentage of excess BMI loss being 82.08 ± 9.83 kg for the follow up
group and 74.88 ± 8.75 kg for those without follow up [27].
3.2. Complications and management
Chang SH et al reported that the mortality rate for all bariatric procedures within 30 days was
0.08% (95% CI, 0.01%-0.24%); the mortality rate after 30 days was 0.31% (95% CI, 0.01%-0.75%)
[28]. Mortality after LSG is exceedingly rare, the 30 days mortality being 0.11% and 1 year
mortality of 0.21% [29]. The 30 day morbidity of sleeve gastrectomy is 5.61% which is higher
in comparison to the laparoscopic adjustable gastric band of 1.44% but similar to that of the
gastric bypass of 5.91% [29].
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While the general complications of bariatric procedures remain unchanged among procedures,
we will discuss important complications specific to sleeve gastrectomy. Staple line leakage,
strictures, and gastrointestinal reflux are the most common complications after LSG.
3.2.1. Leak
Staple line leaks can be divided into acute (< 7 days), early (1-6 weeks), late (after 6 weeks) and
chronic (after 12 weeks) [10]. The risk of a leak after LSG was quoted to be 2.4% with 89% of
these leaks occurring in the proximal third of the stomach near the angle of His [30]. The
pathophysiology of post sleeve is multifactorial and include
a. Tissue Ischemia from
i. Excessive devascularisation resulting in ischemia of tissue near angle of His
ii. Removal of fat pad at angle of His
b. Faulty stapling technique
i. Use of improper staple height leading to poor B formation of staples
ii. Stapling across esophageal fibers at gastroesophageal junction muscle fibers
c. Functional or anatomical obstruction of gastric tube further increasing intra-gastric
pressure of an already elevated pressure system. The sleeve is considered a high pressure
tube because there are anatomical sphincters at both ends i.e. the lower esophageal
sphincter and the pylorus. This can be contributed by
i. Creation of a gastric tube that is not cylindrical shape as shown in the last three
drawing of figure 9 results in a high pressure being built at the proximal most corner
of the staple line based on Laplace Law and thus higher chances of leak at the proximal
1/3rd of the tubular stomach
 
Figure 9. Possible shapes of sleeve created by improper stapling
ii. A staple line that is spiral shaped can result in functional obstruction of the sleeve
and a high pressure system develops
iii. Stapling too close to the incisura results in anatomical narrowing, a preventable cause
of leak
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iv. Post sleeve gastrectomy the tubular sleeve can acquire various shapes-"S" or "L" shape
that can potential result in a high pressure system.
A detailed discussion of leak management is beyond the scope of this chapter. The diagnosis
of a leak can be made clinically where patients have fever, tachycardia and abdominal pain.
The diagnosis can be confirmed with a computerized tomography scan of the abdomen and
pelvis or a oral contrast study like gastrograffin meal (Figure 10) The management of the
patients with suspected leaks depends first, on whether these patients are haemodynamically
stable. In patients who are well with small contained leaks, non-operative management with
percutaneous radiological drainage, endoscopic stenting and supportive therapy with
antibiotics and total parenteral nutrition has been demonstrated to be effective [31]. In patients
who are septic and suspected to have contained or uncontained leaks, immediate operation
for washout and drainage of the contaminated field is indicated. These patients will need
nutritional support via total parenteral nutrition (TPN), or enteral nutrition via a feeding
jejunostomy inserted at time of emergency surgery (preferred option) or naso-jejunal feeding
tube. The following interventions (Figure 11) have been described as options in management
of simple sleeve leak but they have to be individualized to circumstances and resources at
individual centers. For more complex leaks with pleural, bronchial and pulmonary fistulae,
detailed discussion with the thoracic surgeon is needed prior to intervention.
Figure 10. CT scan showing collection and leak of contrast from a proximal sleeve leak
1. Simple suture repair
2. Suture repair with omental patch+/-pyloroplasty
3. El Hassan et al. described a novel method of cannulating a leak site via endoscopy and
laparoscopy with a T tube in patients presenting with early leaks, therefore convert‐
ing the leak site into a controlled fistula together with wide drainage of the abdomi‐
nal cavity [32].
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4. Loop drainage: using a free loop of jejunum anastomosed to the leak site
5. Transection of gastroesophageal junction and proximal esophago-jejunostomy leaving
gastric tube in place
6. Total gastrectomy with esophago-jejunostomy
7. However currently the most favored approach for acute leak is stenting. Baltazar first
reported the use of coated self-expanding stents (CSES) in patients with gastric leaks post
sleeve gastrectomy; successful resolution of the leak was reported in 4 out of the 5 patients
who underwent CSES. None out of 5 patients required a re-operation and all patients
recovered within 6 to 8 weeks. In our opinion early stenting help because stenting
a. Obliterates the defect thus preventing on going leak and thus helps control sepsis
b. Neutralises pressure in the stomach as it traverses gastroesophageal junction to across
pylorus
c. It corrects any abnormal axis along the sleeved tube especially acute bends at incisura
d. Promotes healing by allowing tissue apposition and omental adherence
e. Reduces the risk of gastro-atmospheric fistula formation
f. Prevents on going air leak into abdominal cavity in patients who need BIPAP support.
Conservative 
Suture repair 
± Omental patch or 
pyloroplasty  
T –Tube  Loop Drainage  
EJ 
Anastomosis   
Leak exclusion Total gastrectomy Stenting 
Figure 11. Approaches to sleeve leak
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8. For chronic leak with small cavities, endoscopic septoplasty of the bridging stomach wall
can be considered
9. Use of tissue glue for closure of chronic fistula
10. Use of endoscopic vacuum therapy (Endosponge) is now a novel approach to upper
gastrointestinal tracts and well as the over the scope clips [33].
3.2.2. Strictures / Gastric volvulus
The formation of strictures and gastric pouch stenosis is an uncommon but important com‐
plication of LSG. The mean stricture rate in a meta-analysis of 4888 patients who have
undergone LSG was 0.5% [30]. Regurgitation is the most common presenting complaint for
patients with significant stenosis with the most common site of stenosis at the angular incisura.
A smaller bougie size used to size the sleeve is associated with a greater risk for developing
of strictures post operatively. In patients whom strictures are suspected, assessment can be via
contrast swallow studies or endoscopy. The latter also allows for dilatation to be performed
in the same setting. After gastroscopy in patients with short segment stenosis dilatation with
or with out stenting is an option, should they respond to this treatment repeat dilatation is
advisable. In cases of failed dilatation therapy or long segment stenosis, revisional surgery in
the form of conversion to other procedures like gastric bypass or stricturoplasty may be
considered. Eubanks reported that in patients who underwent stenting for strictures, 84%
achieved immediate symptomatic control and subsequent resolution of the stricture. 16% (1
out of 6 patients) had unsuccessful stent treatment [34, 35]. Burgos also reported success in the
use of endoscopic balloon dilatation (preferably a Rigilflex balloon) and endoscopic bougie
dilatation in the treatment of stricture post sleeve gastrectomy [34]. In patients with excessive
length of stricture where endoscopic dilatation was not possible, Dapri reported that laparo‐
scopic seromyotomy enabled patients to tolerate regular diet with improvement in mean
dysphagia score. The aim of the procedure was to achieve a myotomy 1 cm beyond the stenosis
proximally and distally [36]. Conversion to a roux-en-Y bypass is the last resort for patients
with strictures post sleeve gastrectomy. Other options include stricturoplasty, gastro-gastro‐
stomy and gastrectomy [37].
Gastric volvulus post sleeve gastrectomy is a rare complication. After sleeve gastrectomy the
stomach has no fixation along its greater curve, this together with the increased laxity of tissue
after weight loss increases the risk of a gastric volvulus. Classically patients present with the
Borchardt clinical triad of epigastric pain, retching and inability to pass a nasogastric tube.
Laparoscopic fixation of the gastric tube as one would do for congenital malrotation of the
stomach will fix the problem.
3.2.3. Gastroesophageal reflux disease (GERD)
In patients with symptoms of pre-existing reflux prior to surgery, Roux-en-Y bypass should
be the treatment of choice instead of sleeve gastrectomy. A recent review of the Bariatric
Outcomes Longitudinal Database with 4832 patients concluded that LSG did not reliably
relieve or improve GERD symptoms and that preoperative GERD was associated with worse
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outcomes and decreased weight loss with LSG and thus may be a relative contraindication [12].
Institutional practices may vary; some like ours do routine preoperative gastroscopy to
establish any reflux esophagitis and exclude the presence of hiatus hernia and if a hiatal hernia
is found we would in asymptomatic patients suture repair the hiatal hernia, the surgeon should
actively look out for a hiatal hernia intraoperatively and repair the hernia if it is identified. [10]
Soricelli et al compared their obese patients with GERD undergoing sleeve with or without
hiatal hernia repair and reported 80.4% versus 57.9% remission of GERD and persistent GERD
in 7.5% versus 42.2% respectively [38].
The notion that sleeve gastrectomy is a refluxogenic operation remains controversial, as Chiu
S et al reviewed 15 published reports of which 4 found sleeve to increase reflux and 7 showed
reduction in prevalence of GERD [39]. The anatomic and physiological factors influencing
GERD after sleeve gastrectomy are listed as such
a. Worsen GERD
Decrease in gastric emptying
Lower LES pressure
Blunting angle of HIS
Decrease in gastric compliance and volume
Increase gastric pressure
Dilated proximal sleeve (technical) and fundus regeneration,
Angulation, volvulus of sleeve
Gastric atony
b. GERD Improvement
accelerated gastric emptying
weight loss
reduced acid production
removal of fundus (Source of relaxation waves to LES)
Reduced wall tension (Laplace's Law)
In patients who develop reflux symptoms after sleeve gastrectomy, the first line treatment
should be with proton pump inhibitors [10]. Early reports have shown that in patients with
GERD but refuse gastric bypass, laparoscopic Nissen fundoplication with gastric plication may
be an acceptable weight loss option but long-term weight loss data is still required [40].
3.2.4. Nutritional complications
As LSG is a relatively young operation, there is a lack of reliable data arising from long-term
follow up of patients who have undergone the procedure. Being a restrictive procedure, it is
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postulated that no long-term nutritional deficiencies should result from laparoscopic sleeve
gastrectomy unless there is inadequate intake of nutrients. If a large sleeve has been resected,
Vitamin B12 and resultant megaloblastic anaemia may result due to the lack of Intrinsic factor
produced by the remnant stomach. In a cross sectional study reported during a mean follow
up period of 4 years post gastric bypass or LSG, patients were identified with several micro‐
nutrient deficiencies, including vitamin D, folate, and vitamin B12. LSG had a more favorable
effect on the metabolism of vitamin B12 compared with gastric bypass [41]. Thus, postoperative
prophylactic iron and B12 supplementation, in addition to general multivitamin and mineral
supplementation, is recommended based on the comparable deficiency risk.
4. Outcomes
4.1. Weight loss
A meta-analysis in 2012 comprising of 12,129 patients showed that mean percentage of excess
weight loss (EWL) at 12 months follow up was 59.0% [42], and this further increased to 64.5%
and 66.0% at 24 and 36 months follow up respectively [42]. At 48 months follow up, %EWL
declined to 60.9% but this decline was not statistically significant. The same paper also
elucidated that patients who underwent Laparoscopic Roux-en-Y bypass had significantly
higher %EWL at 12 months follow up but this difference was negligible at 24 months. In a
recent review of European data, mean excess weight loss was 68.4%, and 67.4% after 1 and 2
years respectively. Excess weight loss peaked at 70.5% at the 4-year mark before decreasing to
58.3% at the 5-year mark. The authors concluded that the long-term results regarding weight
loss were satisfactory [43]. Among super obese patients, the reported mean EWL is be 52%,
43%, 46% at 72, 84 and 96 months follow up respectively [44].
Durability of LSG has been debated and available data does suggest that it is durable. A review
of 492 patients with follow-up of at least 5 years after laparoscopic sleeve gastrectomy (373 at
5 years, 72 at 6 years, 13 at 7 years, and 34 at 8 or more years) was performed by Daimantis T
at al [45]. Mean preoperative body mass index in all 16 studies was 49.2 kg/m2. The mean
percentage excess weight loss (%EWL) was 62.3%, 53.8%, 43%, and 54.8% at 5, 6, 7, and 8 or
more years after LSG, respectively [45]. The overall mean %EWL (defined as the average
%EWL at 5 or more years after LSG) was 59.3% (12 studies, n=377 patients). The overall attrition
rate was 31.2% (13 studies). They concluded that the existing data supports the role of LSG in
the treatment of morbid obesity. It seems to maintain its well-documented weight loss outcome
at 5 or more years postoperatively, with the overall mean %EWL at 5 or more years after LSG
still remaining in excess of 50%.
4.2. Eating behavior
Several studies had elicited a change of eating behavior following bariatric surgery. Schweiger
et al [46] studied the effect of different bariatric operations on food tolerance and quality of
eating. On a score of 1 to 27 with 27 points standing for excellent quality of eating, there was
no significant difference between patients who underwent RYGB, LAGB, SG and BPD at 3-6
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months follow-up. At 6-12 months and long-term follow-up, patients who underwent sleeve
gastrectomy achieved a score of 22.27+/-4.66 and 20.25+/-4.9 respectively. Adjusting for other
variables, the total score in the 3 follow up periods was 20.1 for RGYB, 14.3 for LAGB, 19.7 for
SG and 21.6 for BPD/DS patients. Food tolerance at 2-4 years post surgery was also shown to
be best after LSG, followed closely by RYGBP [47].
4.3. Quality of life
In a study of 78 consecutive patients who underwent LSG subjected to the Medical outcomes
Study Short Form Questionnaire (SF-36) coupled with the Impact of Weight on Quality of Life-
Lite Questionnaire pre-operatively and 12 months post-operatively, scores show a significant
overall improvement of the scores 12 months post operatively [48]. Subset analysis showed
that lesser patients reported improvement in self-esteem if they suffered complications as a
result of the surgery or had negative or moderate loss of weight compared to those who had
excellent or satisfactory loss of weight [48]. Studies have also shown that the perceived quality
of life after LSG is better compared to LAGB [47, 49]. However, LSG is the only truly irreversible
procedure.
5. Sleeve as a metabolic procedure
a. Proposed mechanisms of T2 DM remission
Multiple studies have recently demonstrated that patients with raised BMI and diabetes
experience remission of T2DM after laparoscopic sleeve gastrectomy. In a meta-analysis of 27
studies including 673 patients by Gill et al [50], it was shown that DM resolved in 66.2% of
patients and improved in another 26.9% with a mean decrease of 1.7 in HbA1c after sleeve
gastrectomy at mean follow up of 13 months. Perathoner et al reported a resolution rate of 85%
and 50% for Type 2 diabetes mellitus and dyslipidemia respectively in his patients [51]. LSG
has been shown to be superior to intensive medical therapy in the resolution of comorbidities
and improved quality of life [52].
The mechanism behind T2DM remission following LSG has not been clearly defined. It has
been postulated that decreasing oral intake and decreasing insulin resistance instead of
increase in insulin secretion is the reason behind T2DM remission. It has been found that in
patients who underwent sleeve gastrectomy, their postprandial levels of glucagon like peptide
(GLP-1) and total peptide YY (PYY) levels increased significantly at 6 weeks post operation
and remained elevated for at least 1 year [53]. By reducing the volume of the stomach, chyme
could theoretically be exposed to the L cells earlier in the small bowel earlier, resulting in earlier
production of hind gut hormones. Melissas J et al in their gastric emptying study demonstrated
faster gastric emptying after sleeve gastrectomy [54]. It has also been postulated that there is
restoration of the first phase of insulin secretion after sleeve gastrectomy. N Basso et al reported
his "Gastric hypothesis" that a loss in HCL in the stomach stimulated release of GRP which in
turn stimulates the release of GLP-1 [55]. GLP-1 initiates what is known as the incretin effect,
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which increases insulin secretion while inhibiting glucagon release, thereby leading to better
glucose hemostasis.
Ghrelin, an appetite stimulant, produces the orexigenic (appetite stimulating) effects via
stimulation of neuropeptide Y from the hypothalamus. Ghrelin is mainly produced by the
oxyntic cells of the stomach, and has been implicated in obesity and metabolic syndrome. Diet
induced weight loss raises circulating ghrelin levels. In sleeve gastrectomy patients, ghrelin
levels was markedly reduced and remained low for several months after the operation. The
reduction in serum ghrelin levels persisted at five year follow-up post sleeve gastrectomy [56].
Ghrelin not only increases one’ appetite but also has counter insulin effects which causes
increased insulin resistance. A decrease in ghrelin levels hence, would partly explain improved
glucose hemostasis in post SG patients [57]. Most authors would agree that the effect of T2 DM
resolution is not due to solely one hormone, but the added effects of appetite suppression and
regulation of foregut (e.g. ghrelin) and hindgut (e.g. GLP-1) hormones resulting in improved
glucose control overall. PYY a hormone co-secreted with GLP 1 from the distal intestine after
meals. It increases insulin sensitivity and also inhibits the hypothalamic production of
neuropeptide Y. PYY levels are increased after either sleeve gastrectomy or gastric bypass [58].
b. Metabolic outcomes
Increasingly, more trials have demonstrated the effectiveness of SG for excess weight loss.
Himpens et al reported the percentage excess weight loss (EWL) after sleeve gastrectomy as
77.5% and 57.3% at 3 and 6 years respectively [59].
Direct comparison of medical versus bariatric surgical management of obesity and diabetes
was performed in the STAMPEDE prospective randomized controlled trial at the Cleveland
Clinic [60]. Gastric bypass (Roux-en-Y) or sleeve gastrectomy provided a mean percentage
reduction in weight from baseline of 24.5±9.1% and 21.1±8.9% respectively, versus 4.2±8.3% in
the intensive medical group. Regarding diabetes, the success rate for reduction in HbA1c to
6.0% at 36 months was met by 5% of the patients in the medical-therapy group, as compared
with 38% of those in the gastric-bypass group (P<0.001) and 24% of those in the sleeve-
gastrectomy group (P=0.01) respectively). As a result, lesser medications for diabetes, hyper‐
tension and hyperlipidaemia were needed with composite improvement in all parameters of
metabolic syndrome. Long-term follow up of sleeve gastrectomy patients at 6-8 years showed
a 77% improvement or remission of diabetes [44].
Apart from T2 DM remission, LSG patients also have improved overall cardiovascular risk
profiles with improved in dyslipidemia as well as improved blood pressure control.
A systematic analysis of 33 studies comprising 3997 patients demonstrated reduction in
hypertension in 75% of cases, with resolution in 58%, at an average follow up of 16.9±9.8
months [61]. Cardiac remodeling following sleeve gastrectomy has been shown on echocar‐
diography. Reduced left ventricular mass, septum and posterior wall thickness, was demon‐
strated in the study by Cavarretta et al, resulting in improvement in cardiac function [62]. Lipid
profile improvement, specifically HDL and triglyceride levels, total cholesterol/HDL and
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triglyceride/HDL ratios at one year follow-up have been reported without lowering of total
cholesterol and LDL levels after sleeve gastrectomy [63].
The Asian population in general is known to develop metabolic syndrome at lower BMIs in
comparison to their Caucasian counterparts and hence, studies have reported outcomes from
Asia in this cohort. In Asian populations with T2DM and non-morbid obesity (BMI 25-35kg/
m2), sleeve gastrectomy has demonstrated up to 50% resolution in diabetes at 1 year [64]. The
principal mechanism is thought to be related to calorie restriction and weight loss, and C-
peptide levels returning to >3ng/ml appears to be the most reliable marker of resolution.
5.1. Sleeve gastrectomy as a revisional procedure
Revising a restrictive procedure to yet another revisional procedure and even more to the same
procedure does not sound promising to many. However for patients where technical failure
has led to failure to lose weight or weight regain, re-sleeve is an option. Rebibo L et all reported
15 patients undergoing repeat sleeve and compared to 30 matched primary sleeve patients.
The weight loss for the re-sleeve group was 66% versus 77% for the primary sleeve group at
12 months, which was deemed similar [65]. Cheung et al reviewed the literature on procedures
after failed sleeve and concluded that re-sleeve was associated with good weight loss and its
technically less challenging nature may make its clinical use more acceptable [66].
Also, sleeve for failed gastric band and vertical banded gastroplasty is a good and effective
revisional procedure with 60% EWL at 26 months follow up [67]. Where sleeve took off as a
first stage procedure of duodenal switch, it is also finding its way as a first stage procedure for
conversion of failed gastric bypass to duodenal switch and has been shown to be safe and
effective, leaving patients in better condition to have a duodenal switch [68].
5.2. Sleeve gastrectomy in combination with other bariatric procedures
Gastric bypass has a long history and long-term results support its efficacy in treating obese
patients with metabolic disorders. It is an established fact that there are mechanisms beyond
weight loss that are responsible for the excellent metabolic outcomes of gastric bypass and that
these are related to bypassing the foregut. In order to maximize the scope of sleeve gastrectomy
as a metabolic procedure, innovative procedures possessing benefits of both sleeve gastrecto‐
my and gastric bypass are being employed. The sleeve duodeno-jejunal bypass surgery (LSG/
DJB), single-anastomosis duodeno-jejunal bypass with sleeve gastrectomy (SADJB-SG), sleeve
gastrectomy with loop bipartition, and loop duodeno-jejunal bypass with sleeve gastrectomy,
are all largely based on manipulation of foregut. The short-term outcomes have been promis‐
ing . However, they are still considered experimental as both intermediate and long term data
are awaited. Loop duodenal bypass in combination with sleeve gastrectomy for type II diabetes
in individuals with BMI 21-38kg/m2, has shown promising early results, with 91% of achieving
HbA1c of 7.0g/dl at 6 months from surgery [69].
Laparoscopic Roux-En-Y gastric bypass prohibits visualization of the excluded stomach. For
populations with a high risk of gastric cancer, including Japan, the ability to perform endo‐
scopic visualization after bariatric surgery is paramount. In obese individuals with risk factors
Essentials and Controversies in Bariatric Surgery118
such as Helicobacter pylori infection, atrophic gastric mucosa including intestinal metaplasia,
or a family history of gastric cancer, Kasama et al. published a series of laparoscopic sleeve
gastrectomy with duodeno-jejunal bypass [70]. The procedure was found to be feasible, and
safe, with similar EWL to Roux-En-Y gastric bypass. Additional EWL compared to sleeve
gastrectomy was attributed to the added malabsorptive effects of the duodenojejunal bypass.
Sleeve with ileal interposition is an example of sleeve with hindgut manipulation. Patients
undergoing this procedure have demonstrated restoration of insulin sensitivity, with in‐
creased insulin output, and doubling of β-cell glucose sensitivity [71]. The mechanism is
postulated to be intestinal over-stimulation, with increased GLP-1 and incretin secretion.
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